Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke
Authors:
- 1 June 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (6) , 1667-1673
Abstract
Background and Purpose—: The ongoing ageing population is associated with an increasing number of patients with stroke who have preexisting cognitive impairment. This study aimed to evaluate clinical severity in patients with ischemic stroke according to prestroke cognitive status. Methods—: Patients with ischemic stroke were prospectively identified among residents of Dijon, France using a population-based registry (2013–2017). Prestroke cognitive status (no impairment, mild cognitive impairment [MCI], or dementia) was recorded, and severity at stroke onset was measured using the National Institutes of Health Stroke Scale (NIHSS) score. Association between prestroke cognitive status and severity was evaluated using ordinal regression analysis models in which the NIHSS score was considered as a categorical variable. Results—: Among the 1048 patients (mean age, 76.3±15.2 years; 54.0% women), a greater severity was observed in those with MCI (n=132; median NIHSS: 6; interquartile range, 2–15), and those with dementia (n=164; median NIHSS: 7; interquartile range, 3–16), than in patients without cognitive impairment (n=752; median NIHSS: 3; interquartile range, 1–9). MCI (odds ratio [OR], 1.70 [95% CI, 1.21–2.38]; P =0.002) and dementia (OR, 2.24 [95% CI, 1.65–3.04]; P P =0.04 for MCI; OR, 2.16 [95% CI, 1.45–3.22]; P P =0.06 for MCI, and OR, 1.98 [95% CI, 1.26–3.12]; P =0.02 for dementia). The greater severity in patients with prestroke cognitive impairment was not specifically driven by a more severe impairment of either motor or language function. Conclusions—: Patients with preexisting cognitive impairment suffered more severe ischemic stroke. This result could reflect a lower brain tolerance of acute ischemia. Further studies are needed to explore the underlying mechanisms that could be targeted from therapeutic perspectives focusing on neuroprotection.Keywords
This publication has 32 references indexed in Scilit:
- Care and outcomes in patients with ischemic stroke with and without preexisting dementiaNeurology, 2011
- Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trialThe Lancet Neurology, 2009
- Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysisThe Lancet Neurology, 2009
- What Causes Increased Stroke Mortality in Patients with Prestroke Dementia?Cerebrovascular Diseases, 2005
- Influence of prestroke dementia on early and delayed mortality in stroke patientsJournal of Neurology, 2003
- Previous and Incident Dementia as Risk Factors for Mortality in Stroke PatientsStroke, 2002
- Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom OnsetJAMA, 1999
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaborationJournal of Clinical Epidemiology, 1988